SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 331 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $91 | +5.8% | 752 | 0.0% | 0.00% | +100.0% |
| Q2 2023 | $86 | -17.3% | 752 | 0.0% | 0.00% | -50.0% |
| Q1 2023 | $104 | +7.2% | 752 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $97 | -99.9% | 752 | 0.0% | 0.00% | +100.0% |
| Q3 2022 | $83,000 | +48.2% | 752 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $56,000 | -5.1% | 752 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $59,000 | -13.2% | 752 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $68,000 | -2.9% | 752 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $70,000 | -10.3% | 752 | -24.8% | 0.00% | 0.0% |
| Q2 2021 | $78,000 | +4.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $75,000 | -55.9% | 1,000 | 0.0% | 0.00% | -66.7% |
| Q4 2020 | $170,000 | +21.4% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $140,000 | -12.5% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $160,000 | +63.3% | 1,000 | 0.0% | 0.00% | +50.0% |
| Q1 2020 | $98,000 | -24.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $129,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |